Cite
HARVARD Citation
Vercueil, C. et al. (2021). Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia. HemaSphere. 5 (12), pp. e655-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vercueil, C. et al. (2021). Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia. HemaSphere. 5 (12), pp. e655-. [Online].